A possible variant of the neuroleptic malignant syndrome.
A 20-year-old man developed generalised rigidity and signs of autonomic instability following the introduction of therapy with zuclopenthixol decanoate. A diagnosis of NMS was made, despite the absence of hyperthermia. He recovered on treatment with thiamine, dantrolene, and bromocriptine.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003006:Clopenthixol / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D013892:Thioxanthenes / Q000009:adverse effects*
D014150:Antipsychotic Agents; D013892:Thioxanthenes; C029674:clopenthixol decanoate; D003006:Clopenthixol